Clinical Trials Directory

Trials / Conditions / Breast Cancer Triple Negative

Breast Cancer Triple Negative

7 registered clinical trials studyying Breast Cancer Triple Negative — 4 currently recruiting.

StatusTrialSponsorPhase
WithdrawnA Study to Evaluate the Intratumoral Influenza Vaccine Administration in Patients With Breast Cancer
NCT06229392
Rush University Medical CenterPhase 1
Not Yet RecruitingTemozolomide Monotherapy or in Combination With Olaparib in Patients With Triple Negative Breast Cancer (TNBC)
NCT05128734
AHS Cancer Control AlbertaPhase 2
RecruitingNeoadjuvant, SBRT With Intratumoural Pembrolizumab Followed by Neoadjuvant Chemotherapy in Breast Cancer
NCT07188246
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sPhase 2
RecruitingTIL Gean Therapy Combined With Immunotherapy for Advanced or Metastatic Refractory Breast Cancer
NCT06532812
Essen BiotechPhase 1 / Phase 2
RecruitingEvaluating and Monitoring Immune and Clinical Responses in Early-Stage Triple Negative Breast Cancer Undergoin
NCT05877859
Emory University—
UnknownNeoadjuvant Goserelin for Triple Negative Breast Cancer
NCT03444025
Kasr El Aini HospitalPhase 2
WithdrawnMirvetuximab Soravtansine (IMG853) in Folate Receptor Alpha-expressing TNBC
NCT03045393
Duke UniversityPhase 1